These agents are now being explored not only as a strategy to offset the side effects of GLP-1 analogs, but also as direct therapeutics for a range of metabolic disorders, including obesity and diabetes
Gastric motility disorders: management that optimizes nutritional status
Hassanein 1 , Noora Alqassim 1 , Julian Diaz-Moreno 1 , Abdul Rahman Khan 1 , Ahmed Atalla 1 , Noha Abdelgelil 1 , Amir Hassanein 1 , Fatma Barakat 1 , Anna Marie Hefner 1 , Deanna Oliver 1 , Clinton Nichols 2 and James Lyon 2 , (1)Southern California Liver Centers, (2)San Diego Imaging Background: The incidence and mortality of HCC continues to be on the rise in the US
Long-Term Safety: Honestly Unknown Retatrutides longest study data is 68 weeks
Improved Insulin Sensitivity: Enhances glucose metabolism and may support blood sugar regulation, making it a potential tool in managing metabolic syndrome and type 2 diabetes